References
- Dillman RO, Seagren SL, Propert KJ, et al. A randomised trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990; 323: 940–5.
- Dillman RO, Seagren SL, Herndon J, et al. Randomised trial of induction chemotherapy ± radiation therapy versus radia-tion therapy alone in stage III non-small cell lung cancer. Five-year follow-up of CALGB. Proc Am Soc Clin Oncol 1993; 12 (Abstr 1092): 329.
- Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 1995; 87: 198–205.
- Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in non-resectable non-small cell lung cancer: first analysis of a randomised trial in 353 patients. J Natl Cancer Inst 1991; 83: 417–23.
- Le Chevalier T, Arriagada R, Tarayre M, et al. Correspon-dence—Significant effect of adjuvant chemotherapy on sur-vival in locally advanced non-small cell lung cancer. J Natl Cancer Inst 1992; 84: 58 (letter).
- Wolf M, Hans K, Becker H, et al. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radio-therapy in unresectable locally advanced non-small cell lung cancer. Semin Oncol 1994; 21 (Suppl 4): 42–7.
- Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 ran-domised clinical trials. Br Med J 1995; 311: 899–909.
- Schaake-Koning C, Bogaert WVD, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992; 326: 524–30.
- Le Chevalier T, Pujol JL, Douillard JY, et al. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Semin Oncol 1994; 21 (Suppl 1): 28–33.
- Tan EH, Ang PT, Wee J, et al. Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer. Acta Oncol 1999; 38: 619–22.